Menu
Search

Tag: Clinicalstage biopharmaceutical company

Browse exclusive Tags!

Annexon’s CEO to Present at J.P. Morgan Healthcare Conference on Jan. 10, US

0
Annexon Biosciences, a clinical-stage biopharmaceutical company, is set to present at the J.P. Morgan Healthcare Conference on Jan. 10. CEO Douglas Love will discuss their novel approach to complement-based medicines for inflammatory-related diseases. Don't miss the live webcast!

Adial Pharmaceuticals Wins Frost & Sullivan’s Precision Medicine Award, Raises $4M for Addiction Disorders Treatment

0
Adial Pharmaceuticals receives Precision Medicine Award and secures funding, advancing addiction disorders treatment. Learn more here.

Day One Biopharmaceuticals to Present at Piper Sandler Healthcare Conference

0
Day One Biopharmaceuticals presents at Piper Sandler Healthcare Conference to discuss its dedication to pediatric cancer treatment. Learn more on the website.

HilleVax Plans $100M Public Offering to Advance Novel Vaccine Development

0
HilleVax announces $100M public offering to accelerate development of HIL-214 vaccine for norovirus-induced gastroenteritis. Learn more about their mission to improve global health outcomes.

Popular

Annexon Grants 275,000 Share Option to Chief Medical Officer, Dr. Jamie Dananberg

Equity Market 0
Annexon awards equity to Chief Medical Officer, Dr. Jamie Dananberg, reinforcing the company's commitment to complement medicines and transformative therapies.

Adial Pharmaceuticals Wins Frost & Sullivan’s Precision Medicine Award, Raises $4M for Addiction Disorders Treatment

Health 0
Adial Pharmaceuticals receives Precision Medicine Award and secures funding, advancing addiction disorders treatment. Learn more here.

DiaMedica to Release Q2 2023 Financial Results and Provide Business Update

Business 0
Discover the latest updates on DiaMedica Therapeutics' second-quarter financial results and upcoming conference call. Learn about their focus on acute ischemic stroke treatment. Visit their website now!

ONL Therapeutics Enrolls 135+ Patients in Phase 2 Trial of ONL1204 for Retinal Disease: Topline Data Expected 1H2024, US

Health 0
ONL Therapeutics achieves milestone in Phase 2 trial of ONL1204 Ophthalmic Solution for retinal disease - 135 patients enrolled in 4 months.

Subscribe

spot_imgspot_img

About us

Welcome to The Reportify Media Limited, your trusted source for comprehensive and reliable news reports. We are dedicated to bringing you the latest updates and insightful analysis on global events, politics, business, technology, and more. Stay informed and engaged with our well-researched articles, in-depth features, and thought-provoking perspectives. Join our community of informed readers as we navigate the complex world of news together.

Company

The latest

Revolutionary Small Business Exchange Network Connects Sellers and Buyers

Business 0
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.

District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US

Politics 0
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.

Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US

General 0
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.

Subscribe

© 2023 The Reportify Media Limited. All Rights Reserved.